Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Sally Bakewell, Carol Massar and Tim Stenovec.
- Moderna (MRNA) and Merck (MRK) shares continued to gain on investor enthusiasm over their new personalized cancer vaccine. Earlier in the week, Moderna jumped to its biggest intraday gain on record.
- Boston Beer (SAM) shares dropped in trading on Friday, after the alcoholic beverage maker announced Chief Financial Officer Diego Reynoso will be leaving the company on Sept. 14 to accept a new opportunity. Citi views Reynoso’s exit as a “meaningful loss” to the Samuel Adams maker given his key role in the company’s margin recovery program.
- Ubiquiti (UI) shares fell the most since May after the wireless-network equipment provider posted fiscal fourth-quarter gross margin that shrank from the third quarter. The margin was hurt by higher costs of components and shipping.
See omnystudio.com/listener for privacy information.

Today’s biggest winners and losers in the stock market.
On this episode of Stock Movers:
Mining and royalty stocks are rising on Friday as bullion extended gains after the US Treasury’s unexpected ramp-up in buybacks of long-dated government debt and copper’s rise amid a supply squeeze. Shares of Newmont Corp. (NEM) led the sector higher as spot gold prices rose as much as 5.2% on Friday, putting it on track for its third weekly gain.
Shares of Ross Stores (ROST) gained by the most in three months in the Friday trade. That’s after the off-price retailer boosted its earnings per share forecast for the full year. The company said it saw strength throughout the second quarter, with comparable store sales growth supported by “both an increase in new customers and higher engagement from existing customers.”
Shares of Merck (MRK) climbed gain as much as 3.7% to top Wednesday’s record high. Merck and partner Moderna (MRNA) reported mid-week that their personalized cancer vaccine combined with Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. Shares of Moderna moved higher after the stock’s worst ever daily slide on Thursday - one day after the drugmaker’s record 177% surge that stemmed from a clinical trial win.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Newmont (NEM) shares rise. Mining and royalty stocks are rising on Friday as bullion extended gains after the US Treasury’s unexpected ramp-up in buybacks of long-dated government debt and copper’s rise amid a supply squeeze.
- Ross Stores (ROST) shares climb. The off-price retailer boosted its earnings per share forecast for the full year. The company said it saw strength throughout the second quarter, with comparable store sales growth supported by “both an increase in new customers and higher engagement from existing customers.”
- Nvidia (NVDA) shares are mixed. According to the Wall Street Journal, Nvidia is in advanced discussions to make an investment in Cloverleaf Infrastructure, a company that arranges power for data-center projects. The company also reports quarterly earnings next week.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Strategy (MSTR) shares jump. President Donald Trump called for Congress to pass the Clarity Act, a crypto market structure bill that’s stalled over disagreements concerning ethics provisions. The bill failed to come to a vote before the Senate’s August recess.
- Ross Stores (ROST) shares climb. The off-price retailer boosted its earnings per share forecast for the full year. The company said it saw strength throughout the second quarter, with comparable store sales growth supported by “both an increase in new customers and higher engagement from existing customers.”
- Broadcom (AVGO) shares rise. Broadcom Inc. is in talks with lenders to raise more than $60 billion in debt for an AI chip financing deal that will benefit Anthropic PBC and other companies. The financing may include a roughly $30 billion junior debt tranche and a senior-secured tranche that could range from about $60 billion to $70 billion. The potential deal would help firms including Anthropic access chips and other key AI infrastructure, with talks ongoing and details subject to change.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Broadcom (AVGO) is in talks with a group of lenders to raise more than $60 billion in debt for an AI chip financing deal that will benefit Anthropic PBC and other companies, according to people with knowledge of the matter.
- Ross Stores (ROST) shares climb after the off-price retailer boosted its earnings per share forecast for the full year. The company said it saw strength throughout the second quarter, with comparable store sales growth supported by “both an increase in new customers and higher engagement from existing customers.”
- BJ's Wholesale (BJ) boosted its adjusted earnings per share guidance for the full year; the guidance beat the average analyst estimate.
See omnystudio.com/listener for privacy information.